Abstract
PEROXISOMES are cytoplasmic organelles which are important in mammals in modulation of lipid homeostasis, including the metabolism of long-chain fatty acids and conversion of cholesterol to bile salts (reviewed in refs 1 and 2). Amphipathic carboxylates such as clofibric acid have been used in man as hypolipidaemic agents and in rodents they stimulate the proliferation of peroxisomes. These agents, termed peroxisome proliferators, and all-trans retinoic acid activate genes involved in peroxisomal-mediated β-oxidation of fatty acids1–4. Here we show that the receptor activated by peroxisome proliferators5 and the retinoid X receptor-α (ref. 6) form a heterodimer that activates acyl-CoA oxidase gene expression in response to either clofibric acid or the retinoid X receptor-α ligand, 9-cis retinoic acid, an all-trans retinoic acid metabolite7,8; simultaneous exposure to both activators results in a synergistic induction of gene expression. These data demonstrate the coupling of the peroxisome proliferator and retinoid signalling pathways and provide evidence for a physiological role for 9-cis retinoic acid in modulating lipid metabolism.
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1
Lazarow, P. B. & Fujiki, Y. A. Rev. Cell Biol. 1, 489–530 (1985).
- 2
Vamecq, J. & Draye, J. P. Essays Biochem. 24, 115–225 (1989).
- 3
Reddy, J. K. & Lalwani, N. D. Crit. Rev. Toxicol. 12, 1–58 (1983).
- 4
Hertz, R. & Bar-Tana, J. Biochem. J. 281, 41–43 (1992).
- 5
Isseman, I. & Green, S. Nature 347, 645–650 (1990).
- 6
Mangelsdorf, D. J., Ong, E. S., Dyck, J. A. & Evans, R. M. Nature 345, 224–229 (1990).
- 7
Heyman, R. A. et al. Cell 68, 397–406 (1992).
- 8
Levin, A. A. et al. Nature 355, 359–361 (1992).
- 9
Osumi, T., Wen, J.-K. & Hashimoto, T. Biochem. biophys. Res. Commun. 175, 866–871 (1991).
- 10
Tugwood, J. D. et al. EMBO J. 11, 433–439 (1992).
- 11
Dreyer, C. et al. Cell 68, 879–887 (1992).
- 12
Mangelsdorf, D. J. et al. Cell 66, 555–561 (1991).
- 13
Kliewer, S. A. et al. Proc. natn. Acad. Sci. U.S.A. 89, 1448–1452 (1992).
- 14
Kliewer, S. A., Umesono, K., Mangelsdorf, D. J. & Evans, R. M. Nature 355, 446–449 (1992).
- 15
Yu, V. C. et al. Cell 67, 1251–1266 (1991).
- 16
Leid, M. et al. Cell 68, 377–395 (1992).
- 17
Zhang, X.-k. et al. Nature 355, 441–446 (1992).
- 18
Umesono, K., Murakami, K. K., Thompson, C. C. & Evans, R. M. Cell 65, 1255–1266 (1991).
- 19
Hijikata, M. et al. J. biol. Chem. 265, 4600–4606 (1990).
- 20
Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Kliewer, S., Umesono, K., Noonan, D. et al. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771–774 (1992). https://doi.org/10.1038/358771a0
Received:
Accepted:
Issue Date:
Further reading
-
Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
PPAR Research (2021)
-
Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
Molecules (2020)
-
RXR Expression in Marine Gastropods with Different Sensitivity to Imposex Development
Scientific Reports (2020)
-
Peroxisome proliferator-activated receptor ɑ (PPARɑ)–cytochrome P450 epoxygenases-soluble epoxide hydrolase axis in ER + PR + HER2− breast cancer
Medical Molecular Morphology (2020)
-
The PPAR Ω Pocket: Renewed Opportunities for Drug Development
PPAR Research (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
